RBC Capital Starts Forward Pharma (FWP) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
JMP Securities Starts Forward Pharma (FWP) at Market Outperform
November 10, 2014 8:06 AM ESTJMP Securities initiated coverage on Forward Pharma (NASDAQ: FWP) with a Market Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Forward Pharma click here. For more ratings news on Forward Pharma click here.
Shares of Forward Pharma closed at $21.05 yesterday.
... More